Literature DB >> 2488110

The costs of treating hypertension.

M Moser1.   

Abstract

Recent surveys in the U.S. have reported, for the first time, that a significant number of patients with hypertension are finding that the cost of medication and treatment in general is an obstacle to treatment. The cost of management of hypertension can be contained if: a) the diagnostic workup is kept simple (this does not include the use of routine echocardiography or 24-hour monitoring) and b) medications that are relatively inexpensive and easily titratable on one or two visits are chosen. Despite some claims to the contrary, there are relatively few instances where significant metabolic changes are noted, regardless of the medication chosen, that require repeated blood determinations or frequent office visits.

Entities:  

Mesh:

Year:  1989        PMID: 2488110     DOI: 10.1007/bf01857624

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  16 in total

1.  The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1988-05

2.  The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1984-05

3.  Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study.

Authors: 
Journal:  JAMA       Date:  1977-01-17       Impact factor: 56.272

4.  Preferences and practices of Americans and their physicians in antihypertensive therapy.

Authors:  G Gallup; H E Cotugno
Journal:  Am J Med       Date:  1986-12-31       Impact factor: 4.965

5.  Alternatives to traditional antihypertensive therapy.

Authors:  R M Zusman
Journal:  Hypertension       Date:  1986-10       Impact factor: 10.190

6.  Long-term management of hypertension; II. Private practice experience.

Authors:  M Moser; C Grellet; P Okin; A Hodas; E Hamill; J Rudick
Journal:  N Y State J Med       Date:  1980-06

7.  Opportunities for improving the cost-effectiveness of antihypertensive treatment.

Authors:  W B Stason
Journal:  Am J Med       Date:  1986-12-31       Impact factor: 4.965

8.  Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1979-12-07       Impact factor: 56.272

9.  Financial cost as an obstacle to hypertension therapy.

Authors:  N B Shulman; B Martinez; D Brogan; A A Carr; C G Miles
Journal:  Am J Public Health       Date:  1986-09       Impact factor: 9.308

10.  The prognostic value of ambulatory blood pressures.

Authors:  D Perloff; M Sokolow; R Cowan
Journal:  JAMA       Date:  1983-05-27       Impact factor: 56.272

View more
  1 in total

Review 1.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.